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Research letter
Cardiomyopathy in patients with epidermolysis
bullosa simplex with mutations in KLHL24
DOI: 10.1111/bjd.16797
DEAR EDITOR, Dominant mutations in KLHL24, encoding for
kelch-like protein 24 (KLHL24), have been implicated in the
pathogenesis of epidermolysis bullosa simplex (EBS). So far,
26 patients from different ethnicities have been reported and
all of them harboured a heterozygous KLHL24 start codon
mutation, with c.1A>G;p.Met1? being the most prevalent.1–3
We aimed to expand the phenotypic spectrum by incorporat-
ing additional findings, in particular dilated cardiomyopathy,










Fig 1. Epidermolysis bullosa simplex due to KLHL24 (c.1A>G, p.1Met?) mutation. (a–h) Clinical photographs of the index patient showing (a) cutis
aplasia at birth; (b, d) generalized blisters healing with scarring and hypo-/hyperpigmentation; (c, e) amelioration of phenotype at 14 years of years;
(f) palmoplantar hyperkeratosis; (g) loss of dermatoglyphics; (h) congenital malrotation of the great toenail; and (i) nail dystrophy. Arrows point to
the clinical features mentioned. (j) Family pedigree: filled black square indicates affected patient with skin fragility and cardiomyopathy (II:3); half-
filled black square indicates affected patient with skin fragility only (III:2); clear symbols indicate unaffected individuals (II:3 and III:2); (–) indicates
wild-type allele and (+) indicates affected allele. NA, not available; EBS, epidermolysis bullosa simplex; DCM, dilated cardiomyopathy. (k) Sequence
chromatograms of affected members depicting the mutation (c.1A>G, p.1Met?) in KLHL24 (Ref Seq: NM_0176443). (l–n) Immunofluorescence
antigen mapping (IFM) showing normal staining for keratin 14 [green; clone: LL002 (Abcam, Cambridge, U.K.)] in (l) control tissue and (m, n)
affected patients. (o–q) Transmission electron micrographs (TEM) showing a striking paucity of intermediate filaments in (o) basal cells along with
(p) prominent subnuclear melanosomes. (q) Alternate thinning and thickening of lamina densa along with some blind off-shoots can also be seen.
Arrows point to the TEM features mentioned. (r) IFM staining showing localization of KLHL24 [red; clone: ab104089 (Abcam)] along the cell
membrane on cultured normal human cardiomyocytes. (s) Masson’s trichrome staining showing interstitial fibrosis and (t) haematoxylin and eosin
staining showing cardiomyocyte hypertrophy in the explanted diseased heart in patient II:3.
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The cutaneous findings identified in our patients (III:2 and
II:3) are mostly consistent with previous reports,1–3 except for
a few additional findings that included loss of dermatoglyph-
ics, hypohidrosis and congenital malrotation of the great toe-
nails (Fig. 1). Intriguingly, the affected father (II:3) had also
developed a rapidly progressive dilated cardiomyopathy of
unknown aetiology at the age of 18 years for which a cardiac
transplantation was necessary within a year of the first clinical
signs being seen. Immunofluorescence antigen mapping (IFM)
of skin biopsies showed normal staining intensities for a set of
diagnostic epidermal proteins, including keratins 5 and 14 in
both the affected members (Fig. 1). However, electron micro-
scopy revealed a striking paucity of intermediate filaments in
the basal keratinocytes along with numerous and prominent
mitochondria,3 suggesting that, although present, keratins 5
and 14 are not able to form a proper intermediate filament
network, thereby pointing to a diagnosis of EBS. In addition,
we also observed large subnuclear melanosomes, abnormal
thinning and thickening of lamina densa with few re-duplica-
tions and blind offshoots (Fig. 1). Whole-exome sequencing
followed by Sanger sequencing confirmed the presence of a
heterozygous KLHL24 mutation (c.1A>G, p.Met1?) in both the
affected individuals (Fig. 1).
Although these findings explained the skin phenotype, it
remained unclear whether the mutation in KLHL24 was respon-
sible for the pathogenesis of cardiomyopathy in the father as
well. Histological features of the explanted heart showed dif-
fuse myocyte hypertrophy and moderate-to-strong interstitial
fibrosis with no infiltrate, signs of stacking or cardiomyocyte
disarray (Fig. 1), consistent with a diagnosis of dilated car-
diomyopathy. Considering the possibility that he might have
had a cardio-cutaneous syndrome or a second genetic condi-
tion due to a mutation in a gene causing isolated dilated car-
diomyopathy, molecular analysis of genes implicated in the
pathogenesis of epidermolysis bullosa, cardio-cutaneous syn-
dromes, hereditary cardiomyopathies and related disorders
was performed but did not reveal any pathogenic variations
(available upon request). Interestingly, He et al. also noted
dilated cardiomyopathy in a 43-year-old patient, although the
age of onset in this patient was unclear.2 Furthermore, Hed-
berg-Olfers et al. reported two patients with a homozygous
KLHL24 nonsense mutation (c.1048G>T, p.E350*) associated
with hypertrophic cardiomyopathy, and validated the associa-
tion in a zebrafish model.4
To better understand this cardiac association, we per-
formed IFM staining on human embryonic stem cell
9-derived cardiomyocytes for the presence of KLHL24.5 Sur-
prisingly, we observed a clear positive staining of KLHL24
along the cell membrane in a distribution pattern similar to
other intercalated disc proteins involved in cardiocutaneous
syndromes (Fig. 1), extending the RNA expression data of
KLHL24 in the heart,1 and providing a clue for a possible
cardiocutaneous syndromic association. Notably, his affected
14-year-old son had a borderline enlarged left ventricle (di-
mensions in the 95th percentile) on two-dimensional
echocardiography, whereas his unaffected 18-year-old
daughter and parents (mother aged 70 years and father
aged 71 years) did not show any cardiac abnormalities.
Cardiomyopathy was not reported in the rest of the family.
This further strengthens the hypothesis that the cardiomy-
opathy might, indeed, be caused by the KLHL24 mutation
and not by unrelated genetic factors.
Given that KLHL24 is shown to be widely expressed in tis-
sues other than skin like brain, kidney, liver, lung and pan-
creas,1 we also screened our patients for possible
abnormalities in those organs. The affected father, besides the
cardiomyopathy, suffers from short- and long-term memory
problems, and muscular weakness with slight ptosis. Renal
dysfunction was also noted; however, this could also be attrib-
uted to the long-term use of ciclosporin for his heart trans-
plant. His affected 14-year-old son, besides his borderline
enlarged heart, reported concentration and learning problems.
No other extracutaneous features were found on screening.
Altogether, the emerging picture is that of a KLHL24 muta-
tion causing a syndromic rather than a skin-only type of epi-
dermolysis bullosa, in which cardiomyopathy may be a
dominant symptom. Other new features in our cases include
cutaneous findings, such as loss of dermatoglyphics, hypo-
hidrosis and congenital malrotation of great toenails, in addi-
tion to mental problems. Future studies are needed to reveal
whether these symptoms are, indeed, part of the KLHL24-
related phenotype. The reason that cardiomyopathy has been
described in only a few of the previously reported patients
may be related to the fact that most of them were under 15
years of age and the symptoms likely display an age-depen-
dent penetrance and/or need additional triggers. We therefore
recommend screening all patients with KLHL24 mutations for
extracutaneous manifestations, particularly cardiomyopathy,
from the early teens onwards.
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